Navigation Links
GenTel acquires GlaxoSmithKline chip platform

Fitchburg, Wis. - Alex Vodenlich believes his life-science company, GenTel BioSciences, has taken a major step with the acquisition of a protein chip platform from GlaxoSmithKline, but just how major could depend on the degree to which the technology improves the quality of data GenTel delivers to customers.

G......

Full article >>> tional data.

Vodenlich said it would have taken GenTel a long time to duplicate the protein chip platform it purchased from GlaxoSmithKline. The platform integrates instruments, web-based software applications, and statistical tools that will enable GenTel to design and screen protein arrays, and analyze multiplex protein micro arrays. He said GenTel's customer base, including large pha......

Full article >>> /b>

In conjunction with the acquisition, GenTel has added to its staff Dr. Anna Astriab-Fisher, who will serve as vice president of assay development, and Bryan Reep, who brings expertise in the production of arrays. Assays are procedures in which the properties of an object are measured; arrays are genetic tools used to detect variations in DNA and susceptibility to disease, and measure ......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 03/13/07


Related biology technology :

1. New angel capital centered on GenTel agreement with big pharma
2. GenTel licenses next generation cancer research
3. GenTel to distribute cancer research tool
4. GenTel gets federal grant to develop allergy test
5. Madisons GenTel partners with Taiwan firm
6. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
7. GenTel BioSurfaces launches new assay platform
8. GenTel will sell Dutch firms biomolecule labeling technology
9. Bone Care, GenTel, MyWeather
10. GenTel receives $250,000 state loan
11. GenTel claims $900,000 in federal grants this year for biochip research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... ... can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical ... and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented ...
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company ... National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month ... technology and is expected to deliver therapeutic levels of olanzapine for a period of ...
(Date:2/24/2017)... San Diego, Calif. (PRWEB) , ... February 24, 2017 , ... ... African food and wine scene. Making stops in several cities, she gained a ... Her culinary adventure began in Stellenbosch, a town in South Africa’s Western Cape province. ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
Breaking Biology News(10 mins):